📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer. (2019)

First Author: Conteduca V

Attributed to: Leveraging circulating tumour DNA (ctDNA) to dissect the evolutionary genomic dynamics of drug resistance in prostate cancer. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.eururo.2018.09.049

PubMed Identifier: 30773204

Publication URI: http://europepmc.org/abstract/MED/30773204

Type: Journal Article/Review

Volume: 75

Parent Publication: European urology

Issue: 3

ISSN: 0302-2838